T. Phillips

EP1: a novel rabbit monoclonal antibody for detection of oestrogen receptor α

S. Badve, B. Spaulding, I. Vladislav, 2013, Journal of Clinical Pathology.

Development of Standard Estrogen and Progesterone Receptor Immunohistochemical Assays for Selection of Patients for Antihormonal Therapy

D. Allred, J. Askaa, D. Huang, 2007, Applied immunohistochemistry & molecular morphology : AIMM.

Association of tumor PD-L1 expression and immune biomarkers with clinical activity in patients (pts) with advanced solid tumors treated with nivolumab (anti-PD-1; BMS-936558; ONO-4538).

Clive R. Taylor, J. Taube, C. Horak, 2013 .

Programmed death-ligand 1 (PD-L1) expression in various tumor types

Xiaoling Zhang, J. Cogswell, J. Grosso, 2013, Journal of Immunotherapy for Cancer.

1059PPD-L1 Detection and Assay Performance in Squamous Cell Carcinoma of the Head and Neck Using PD-L1 IHC 28-8 pharmDx

S. Álvarez, H. Inzunza, E. Oroudjev, 2017 .

Assay performance of the PD-L1 IHC 28-8 pharmDx assay in squamous cell carcinoma of the head and neck (SCCHN).

S. Álvarez, H. Inzunza, E. Oroudjev, 2017 .

Development of a diagnostic PD-L1 immunohistochemical assay for nivolumab therapy in urothelial carcinoma.

H. Inzunza, E. Oroudjev, J. Novotny, 2017 .

Development of an Automated PD-L1 Immunohistochemistry (IHC) Assay for Non–Small Cell Lung Cancer

Xiaoling Zhang, H. Inzunza, J. Cogswell, 2015, Applied immunohistochemistry & molecular morphology : AIMM.

Development of a Diagnostic Programmed Cell Death 1-Ligand 1 Immunohistochemistry Assay for Nivolumab Therapy in Melanoma

Clive Taylor, Henrik Winther, Xiaoling Zhang, 2017, Applied immunohistochemistry & molecular morphology : AIMM.